HEALTHWDIV CLICKONDETROIT
Judge questions difference between Hegseth's testosterone policy and transgender care for troops
A federal judge has questioned the distinction between Defense Secretary Pete Hegseth's testosterone replacement therapy (TRT) initiative for troops and hormone treatment for transgender men in the military. The inquiry occurs within a lawsuit challenging President Donald Trump's ban on transgender service members, as Judge Ana Reyes orders analysis of medical and logistical similarities between TRT for cisgender and transgender individuals.
Mentioned
Related Signal
Adjacent reporting
- Judge questions difference between Hegseth's testosterone policy and transgender care for troops
- Judge questions difference between Hegseth’s testosterone policy and transgender care for troops
- Appeals court rules Hegseth illegally banned active transgender troops, but can bar new recruits
- Some trans military members banned by Trump allowed to continue service under ruling
- Trump’s transgender military ban driven by ‘desire to harm,’ appeals court rules
- Pentagon policy illegally banned transgender troops from military service, appeals court panel rules